Risk factors for fluconazole-resistant Candida glabrata bloodstream infections - Test2 - elhamkhani - TriplyDB

Risk factors for fluconazole-resistant Candida glabrata bloodstream infections

Risk factors for fluconazole-resistant Candida glabrata bloodstream infections

http://www.wikidata.org/entity/Q33932340

about

Antifungal application of nonantifungal drugs In vitro activity of econazole in comparison with three common antifungal agents against clinical Candida strains isolated from superficial infections The effect of cumulative length of hospital stay on the antifungal resistance of Candida strains isolated from critically ill surgical patients.Recent exposure to caspofungin or fluconazole influences the epidemiology of candidemia: a prospective multicenter study involving 2,441 patients The epidemiology, antifungal use and risk factors of death in elderly patients with candidemia: a multicentre retrospective study.Clinical and economic outcomes of decreased fluconazole susceptibility in patients with Candida glabrata bloodstream infections.Screening of Pharmacologically Active Small Molecule Compounds Identifies Antifungal Agents Against Candida Biofilms Antibiotic exposure as a risk factor for fluconazole-resistant Candida bloodstream infection Effect of reduced vancomycin susceptibility on clinical and economic outcomes in Staphylococcus aureus bacteremia.Risk factors for efflux pump overexpression in fluoroquinolone-resistant Escherichia coli Derivation and validation of clinical prediction rules for reduced vancomycin susceptibility in Staphylococcus aureus bacteraemia.The effect of staphylococcal cassette chromosome mec (SCCmec) type on clinical outcomes in methicillin-resistant Staphylococcus aureus bacteremia.A Prospective Surveillance Study of Candidaemia: Epidemiology, Risk Factors, Antifungal Treatment and Outcome in Hospitalized Patients.Temporal changes in resistance mechanisms in colonizing Escherichia coli isolates with reduced susceptibility to fluoroquinolones Variation in susceptibility of bloodstream isolates of Candida glabrata to fluconazole according to patient age and geographic location in the United States in 2001 to 2007.Azole Antifungal Resistance in Candida albicans and Emerging Non-albicans Candida Species.Development of a Luminex-based multiplex assay for detection of mutations conferring resistance to Echinocandins in Candida glabrata.Impact of antibiotic use during hospitalization on the development of gastrointestinal colonization with Escherichia coli with reduced fluoroquinolone susceptibility.Thriving within the host: Candida spp. interactions with phagocytic cells.The Candida pathogenic species complex.Antifungal drug resistance among Candida species: mechanisms and clinical impact.Azole Resistance in Candida glabrata.Risk factors for fluconazole-resistant candidemia.Cross-resistance between voriconazole and fluconazole for non-albicans Candida infection: a case-case-control study.Occurrence of oral Candida colonization and its risk factors among patients with malignancies in China.Synthesis and Biological Evaluation of Novel Alkyl-Imidazolyl Carbinols and their Esters: Potent Antimycotics.Prior antimicrobial exposure and the risk for bloodstream infection with fluconazole-non-susceptible Candida strains.EUCAST technical note on Candida and micafungin, anidulafungin and fluconazole.Fluconazole-resistant Candida: collateral damage associated with prior antibacterial exposure?Problems related to antifungal prescription: a qualitative study of the views of intensivists.Identification and antifungal susceptibility of Candida species isolated from the urine of patients in a university hospital in Brazil.Jjj1 Is a Negative Regulator of Pdr1-Mediated Fluconazole Resistance in Candida glabrata.

P2860

Q30433553-00591808-8E92-4E0A-BD14-157974C8DA30 Q33851255-767FDD86-053C-4107-9603-AA84F541BFA4 Q33887429-3091C54D-E17D-48B5-A407-517F7F489E5D Q34529026-045BA70D-206A-481F-AB0B-2D29FDAF5940 Q34586566-7B70CAE5-F9DF-4EDB-A96D-EC74E02A4524 Q35558411-E7932474-7CA0-47A1-A3AE-1AB3EE837FBC Q35886365-DEF08F05-7F8A-4E57-87DE-BB2373E8CDC8 Q35941512-4CBA89AB-82C5-4FB4-9812-AC0E5513562C Q36276932-29FEE928-FFC5-4C9A-8424-A78312BB62DD Q36330973-7D7DA0FB-8C36-4323-8D66-BDDA26413F7F Q36456630-83469AAC-DF62-4EB7-A4F5-CB4EC1C5E1F6 Q36457109-F093217E-1856-4FED-9D9F-3ED4E0804183 Q37012419-FEC12BAF-E52C-48A0-8A9A-88D0BB6D62D9 Q37049823-4BD98C6E-46C3-4BA9-B152-593D6547BE55 Q37374850-B51A538C-996E-45B3-9E30-19E43B6A1EC4 Q37580801-0DC89389-C93B-4660-A267-6BB92836C2CC Q37643499-98A9D170-4CCD-4445-9D35-97A897BE659C Q37691788-506E971B-BFF4-4599-BD96-41FFB5599798 Q38077110-4C5125A1-05B2-4CE4-85E6-33B7830CF8FA Q38245727-1190736D-BC9A-4C41-BDE4-E115C3B9EDAD Q38511946-7C916EEC-AA6D-46AC-A498-27399F463678 Q38985818-A70ED180-FBAD-40E6-8A8E-C5CCE1313995 Q39934814-7B8F1F21-DCD3-4567-9FEC-DE2E6ED92AB2 Q40169961-338955A8-F16A-44DC-8AA3-2BBAB58A5A20 Q41085151-EE4BFDB4-D408-475D-ABC7-5905067BD439 Q42042096-CEE398DB-322A-474F-A6EE-3D15327F163F Q43108559-AA7CB6B8-C77C-4019-882A-122F8180B0C5 Q44013179-3077920B-2DF2-4E4F-A3C5-C7B32BCACC02 Q44919501-F548081E-8140-41EF-9880-13E81E1132DF Q45895673-812C6CCB-3689-4064-8D9D-A70DFBA54FE7 Q47147760-ED190AE7-986D-4147-A44B-9EDDDB8E833F Q51149332-8F7B4547-1558-4221-98D8-85BC211454A9

P2860

Risk factors for fluconazole-resistant Candida glabrata bloodstream infections

http://www.wikidata.org/entity/Q33932340

description

2009 nî lūn-bûn

@nan

2009 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Risk factors for fluconazole-resistant Candida glabrata bloodstream infections

@ast

Risk factors for fluconazole-resistant Candida glabrata bloodstream infections

@en

type

label

Risk factors for fluconazole-resistant Candida glabrata bloodstream infections

@ast

Risk factors for fluconazole-resistant Candida glabrata bloodstream infections

@en

prefLabel

Risk factors for fluconazole-resistant Candida glabrata bloodstream infections

@ast

Risk factors for fluconazole-resistant Candida glabrata bloodstream infections

@en

P1433

Q33932340-083C5B8E-7654-43AD-8D50-C36FDE986FB9

P1476

Q33932340-A3DD0949-117F-4D70-9593-A1801D60DEE2

P2093

Q33932340-0DB97D98-B8FB-4D49-8050-3B712768B667

Q33932340-1C860D8A-485D-4F43-8959-97860168902E

Q33932340-30967652-DCA4-4736-8E49-5204F3E5D787

Q33932340-41E11529-1399-4E6F-87C5-86B0FE9F67DC

Q33932340-7AEF2CBB-FEA1-471F-81C6-816A45EA77ED

Q33932340-A14A3C94-EB0D-4376-91C8-D2989191F28B

Q33932340-FC0B6401-6720-44F2-8406-F2AC10410CC5

Q33932340-FD114C15-64B4-4ECF-9855-7F01C079A0F7

P2860

Q33932340-024256F7-6FD1-4594-B3B8-0F11830E6E8C

Q33932340-08D9399D-90E0-4A11-9195-A84F21615B2E

Q33932340-1042E8D2-FE1E-4E29-98BE-772119A9D8D6

Q33932340-2CDE6064-06DA-43D2-809F-74B0EE5B8535

Q33932340-2E5E8537-3682-46A5-8A6D-56638E1CCDA7

Q33932340-3043A0D3-9442-4897-AFA8-6D325AA63D60

Q33932340-314EB061-35A8-492F-98B6-8BCC2A16982D

Q33932340-32384A5D-0C10-49DA-837B-F26180E62232

Q33932340-37F87DE7-6A0C-49D7-A01D-1772CECCBBC9

Q33932340-47219E3D-75AF-4AA8-A5BE-0494FDB97776

P304

Q33932340-9542F313-C101-4B2A-89B7-B646DE5EA820

P31

Q33932340-B5F9D41B-2DD7-49BA-8691-7AADD067AD51

P356

Q33932340-FFC5B699-CAA8-41C1-BC33-E1A1DC720157

P407

Q33932340-36FA87D3-63D2-49BC-8308-B45662FE3A60

P433

Q33932340-01713F08-F83E-4B95-8AB8-3765D3D98E5B

P478

Q33932340-C4252BBE-996F-4266-B1F3-EFD5CF8B5B1B

P577

Q33932340-4C6D5FEB-6B83-49C1-BF4D-69D3B131FFA1

P5875

Q33932340-27AF30A7-735E-4EEA-BD47-028DF9C7E5EF

P698

Q33932340-3A7D7D0D-79F0-4629-8574-DD3A0C748AC8

P921

Q33932340-F10EE2C3-DB2C-4478-A8DE-7D777C48314E

P932

Q33932340-89F4E850-6D5B-43C9-8A25-EB51F089289F

P356

ARCHINTE.169.4.379

P1433

JAMA Internal Medicine

P1476

Risk factors for fluconazole-resistant Candida glabrata bloodstream infections

@en

P2093

Ebbing Lautenbach

http://www.w3.org/2001/XMLSchema#string

Ingi Lee

http://www.w3.org/2001/XMLSchema#string

Irving Nachamkin

http://www.w3.org/2001/XMLSchema#string

Knashawn H Morales

http://www.w3.org/2001/XMLSchema#string

Marie Synnestvedt

http://www.w3.org/2001/XMLSchema#string

Mark G Weiner

http://www.w3.org/2001/XMLSchema#string

Neil O Fishman

http://www.w3.org/2001/XMLSchema#string

Theoklis E Zaoutis

http://www.w3.org/2001/XMLSchema#string

P2860

Candida glabrata: review of epidemiology, pathogenesis, and clinical disease with comparison to C. albicans

Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study

Epidemiology of invasive candidiasis: a persistent public health problem

Nosocomial Candida glabrata colonization: an epidemiologic study.

Mechanisms of azole resistance in clinical isolates of Candida glabrata collected during a hospital survey of antifungal resistance.

Prior antimicrobial therapy and risk for hospital-acquired Candida glabrata and Candida krusei fungemia: a case-case-control study.

Increasing incidence of candidemia: results from a 20-year nationwide study in Iceland.

Role of sentinel surveillance of candidemia: trends in species distribution and antifungal susceptibility.

The impact of candidemia on length of hospital stay, outcome, and overall cost of illness.

Antifungal drug resistance of pathogenic fungi.

P304

379-383

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1001/ARCHINTE.169.4.379

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

169

http://www.w3.org/2001/XMLSchema#string

P577

2009-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

24035394

http://www.w3.org/2001/XMLSchema#string

P698

19237722

http://www.w3.org/2001/XMLSchema#string

P921

Candida glabrata

P932

2890272

http://www.w3.org/2001/XMLSchema#string